Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
71 hedge funds and large institutions have $294M invested in Taro Pharmaceutical Industries Ltd. in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 10 closing their positions.
37% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 19
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less funds holding
Funds holding: 76 → 71 (-5)
14% less capital invested
Capital invested by funds: $342M → $294M (-$48.1M)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$5.53M |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$844K |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$517K |
| 4 |
UBS AM
Chicago,
Illinois
|
+$432K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$416K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.86M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.41M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$1.76M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$1.39M |
| 5 |
JP Morgan Chase
New York
|
-$1.23M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Jane Street
New York
| – | -$255K | -3,547 | Closed |
|
|
TRCT
77
Tower Research Capital (TRC)
New York
| – | -$167K | -2,419 | -100% |
|
|
AFAS
78
Acorn Financial Advisory Services
Reston,
Virginia
| – | -$305K | -1,377 | Closed |
|
79
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$5K | -75 | Closed |
|
|
FWM
80
Focused Wealth Management
Newburgh,
New York
| – | -$2K | -33 | Closed |
|
TARO Hedge Fund Activity: Q3 2021 in Review
71 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q3 2021, worth a combined $294M — down 14% from $342M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TARO and 6 opened new positions — a net loss of 4 holders — while 19 trimmed existing stakes and 26 added.
The largest buyer was Invesco, adding an estimated $5.53M. The largest seller was Fidelity Investments, cutting an estimated $5.86M.
- 71 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q3 2021, down from 76 in Q2 2021.
- Funds reported $294M of Taro Pharmaceutical Industries Ltd. stock for Q3 2021, down 14% quarter-over-quarter.
- 6 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q3 2021 and 10 closed out, a net change of -4 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q3 2021 was Invesco, an estimated $5.53M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q3 2021 was Fidelity Investments, an estimated $5.86M sold.
Based on aggregated 13F filings for Q3 2021.